Choice of the second agent to start alongside metformin should be based on the individual's priorities, preferences, and comorbidities [Grade D, Consensus]
Some employers expressed hope that life-style coaching would allow employees to have an off ramp and stop using GLP-1 drugs after some period of time
[20] Over the course of a 52 week double blind study to detect the efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes, the most common side effects seen were nausea, diarrhea, and vomiting [20]
Is there a role for IGF-1 in the development of second primary cancers
Seino, Y., Fukushima, M., & Yabe, D